Evidence map›Paper›PMID 25409460›Full record

ArticleCancer biotherapy & radiopharmaceuticals2014

Ribosomal protein S15A augments human osteosarcoma cell proliferation in vitro.

Chen Zhang, Ting Zhang, E Song, S W A Himaya, Xianzhen Chen, Longpo Zheng

RetractedErratum issuedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Cancer biotherapy & radiopharmaceuticals, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Cancer biotherapy & radiopharmaceuticals · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Chen Zhang1 Shanghai Tenth People's Hospital, Tongji University School of Medicine , Shanghai, China .
Ting Zhang
E Song
S W A Himaya
Xianzhen Chen
Longpo Zheng
Tongji University · CNShanghai Tenth People's Hospital · CNSoochow University · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a highly conserved housekeeping gene, the biological implications of ribosomal protein S15A (RPS15A) during various processes, including carcinogenesis, remain elusive. Herein, the authors reported that knockdown of RPS15A expression significantly inhibited human osteosarcoma U2OS cell proliferation and colony formation in vitro by using a lentivirus-mediated RNA interference (RNAi) system. Moreover, an excess accumulation of cells in the G0/G1 phase was observed in U2OS cells transduced with lentivirus targeting RPS15A, suggesting that the growth inhibition mediated by RPS15A knockdown in osteosarcoma cells was probably due to the induction of cell cycle arrest. Taken together, this study highlights the crucial role of RPS15A in promoting osteosarcoma cell proliferation, and provides a foundation for further study into the clinical potential of inhibition of RPS15A for the treatment of osteosarcoma.

Indexed as

Bone NeoplasmsCell Cycle CheckpointsCell Line, TumorCell ProliferationG1 PhaseHumansLentivirusOsteosarcomaResting Phase, Cell CycleRibosomal ProteinsRNA InterferenceRibosomal Proteinsribosomal protein S15agrowthosteosarcomaRNA interferenceRPS15A

Identifiers

PMID25409460
PMCPMC4267417
OpenAlexW1431189180

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.